nach oben

Erschienen in:

01.08.2012 | Cardiovascular Disease and Stroke (M Fink and J Safdieh, Section Editors)

Management of Ruptured Brain Arteriovenous Malformations

verfasst von: Brad E. Zacharia, Kerry A. Vaughan, Adam Jacoby, Zachary L. Hickman, Daniel Bodmer, E. Sander Connolly Jr.

Erschienen in: Current Atherosclerosis Reports | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Intracranial arteriovenous malformations (AVMs) are a common cause of stroke in younger patients, and often present as intracerebral hemorrhages (ICH), associated with 10 % to 30 % mortality. Patients who present with a hemorrhage from an AVM should be initially stabilized according to acute management guidelines for ICH. The characteristics of a lesion including its size, location in eloquent tissue, and high-risk features will influence risk of rupture, prognosis, as well as help guide management decisions. Given that rupture is associated with an increased risk of 6 % re-rupture in the year following the initial hemorrhage, versus 1 % to 3 % predicted annual risk in non-ruptured lesions only, definitive treatment is encouraged after ICH stabilization. A rest period of 2 to 6 weeks after hemorrhage is recommended before definitive treatment to avoid disrupting friable parenchyma and the hematoma. Treatment may consist of endovascular embolization, surgical resection, radiosurgery, or a combination of these three interventions based on the lesion.

Friedlander RM. Clinical practice. Arteriovenous malformations of the brain. N Engl J Med. 2007;356(26):2704–12.PubMedCrossRef

Laakso A, Hernesniemi J. Arteriovenous malformations: epidemiology and clinical presentation. Neurosurg Clin N Am. 2012;23(1):1–6.PubMedCrossRef

Steiger H-J, Schmid-Elsaesser R, Muacevic A (2002) Neurosurgery of arteriovenous malformations and fistulas. 473

Ogilvy CS, Stieg PE, Awad I, Brown RD, Kondziolka D, Rosenwasser R, Young WL, Hademenos G, Special Writing Group of the Stroke Council, American Stroke Association. AHA scientific statement: recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke. 2001;32(6):1458–71.PubMedCrossRef

• Aoun SG, Bendok BR, Batjer HH. Acute management of ruptured arteriovenous malformations and dural arteriovenous fistulas. Neurosurg Clin N Am. 2012;23(1):87–103. This article provides an up-to-date, concise review of all relevant studies on the acute management of ruptured lesions.PubMedCrossRef

Al-Shahi R, Warlow C. A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain. 2001;124(Pt 10):1900–26.PubMedCrossRef

• Barr JC, Ogilvy CS. Selection of treatment modalities or observation of arteriovenous malformations. Neurosurg Clin N Am. 2012;23(1):63–75. This article presents concise, evidence-based observations and guidelines for appropriate selection of treatment options for arteriovenous malformations.PubMedCrossRef

•• van Beijnum J, van der Worp HB, Buis DR, Al-Shahi Salman R, Kappelle LJ, Rinkel GJE, van der Sprenkel JWB, Vandertop WP, Algra A, Klijn CJM. Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA. 2011;306(18):2011–9. This review provides a comprehensive understanding of global trends and paradigms in the permanent treatment of arteriovenous malformations.PubMedCrossRef

Mandybur TI, Nazek M. Cerebral arteriovenous malformations. A detailed morphological and immunohistochemical study using actin. Arch Pathol Lab Med. 1990;114(9):970–3.PubMed

10.

Moftakhar P, Hauptman JS, Malkasian D, Martin NA. Cerebral arteriovenous malformations. Part 2: physiology. Neurosurg Focus. 2009;26(5):E11.PubMedCrossRef

11.

Graf CJ, Perret GE, Torner JC. Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg. 1983;58(3):331–7.PubMedCrossRef

12.

Stapf C, Mast H, Sciacca RR, Choi JH, Khaw AV, Connolly ES, Pile-Spellman J, Mohr JP. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66(9):1350–5.PubMedCrossRef

13.

Mast H, Young WL, Koennecke HC, Sciacca RR, Osipov A, Pile-Spellman J, Hacein-Bey L, Duong H, Stein BM, Mohr JP. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet. 1997;350(9084):1065–8.PubMedCrossRef

14.

Forster DM, Steiner L, Håkanson S. Arteriovenous malformations of the brain. A long-term clinical study. J Neurosurg. 1972;37(5):562–70.PubMedCrossRef

15.

van Beijnum J, Lovelock CE, Cordonnier C, Rothwell PM, Klijn CJM, Al-Shahi Salman R, on behalf of the SIVMS Steering Committee and the Oxford Vascular Study. Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies. Brain. 2008;132(2):537–43.PubMedCrossRef

16.

Diringer MN. Intracerebral hemorrhage: pathophysiology and management. Crit Care Med. 1993;21(10):1591–603.PubMedCrossRef

17.

Abdullah AR, Smith EE, Biddinger PD, Kalenderian D, Schwamm LH. Advance hospital notification by EMS in acute stroke is associated with shorter door-to-computed tomography time and increased likelihood of administration of tissue-plasminogen activator. Prehosp Emerg Care. 2008;12(4):426–31.PubMedCrossRef

18.

Morgenstern LB, Hemphill JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41(9):2108–29.PubMedCrossRef

19.

Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med. 2001;29(3):635–40.PubMedCrossRef

20.

Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation. 2007;116(16):e391–413.PubMedCrossRef

21.

Schutz H, Bodeker R, Damian M, Krack P, Dorndorf W. Age-related spontaneous intracerebral hematoma in a German community. Stroke. 1990;21:1412–8.PubMedCrossRef

22.

Sturgeon JD, Folsom AR, Longstreth WT, Shahar E, Rosamond WD, Cushman M. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke. 2007;38(10):2718–25.PubMedCrossRef

23.

Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344(19):1450–60.PubMedCrossRef

24.

Nüssel F, Wegmüller H, Huber P. Comparison of magnetic resonance angiography, magnetic resonance imaging and conventional angiography in cerebral arteriovenous malformation. Neuroradiology. 1991;33(1):56–61.PubMedCrossRef

25.

Anzalone N, Scomazzoni F, Strada L, Patay Z, Scotti G. Intracranial vascular malformations. Eur Radiol. 1998;8(5):685–90.PubMedCrossRef

26.

Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, FAST trial investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358(20):2127–37.PubMedCrossRef

27.

• Adeoye O, Broderick JP. Advances in the management of intracerebral hemorrhage. Nat Rev Neurol. 2010;6(11):593–601. This article eloquently summarizes relevant literature on advances in treatments for intracerebral hemorrhage and provides an important framework for future adoption of new treatment options.PubMedCrossRef

28.

Zhang Y, Reilly KH, Tong W, Xu T, Chen J, Bazzano LA, Qiao D, Ju Z, Chen C-S, He J. Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China. J Hypertens. 2008;26(7):1446–52.PubMedCrossRef

29.

Anderson CS, Huang Y, Arima H, et al. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke. 2010;41(2):307–12.PubMedCrossRef

30.

Qureshi AI, Palesch YY. Antihypertensive treatment of acute cerebral hemorrhage (ATACH) II: design, methods, and rationale. Neurocritical care. 2011. doi:10.1007/s12028-011-9538-3.

31.

Fogelholm R, Murros K, Rissanen A, Avikainen S. Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study. J Neurol Neurosurg Psychiatr. 2005;76(3):349–53.PubMedCrossRef

32.

Schwarz S, Häfner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology. 2000;54(2):354–61.PubMedCrossRef

33.

Kollmar R, Juettler E, Huttner HB, Dörfler A, Staykov D, Kallmuenzer B, Schmutzhard E, Schwab S, Broessner G, for the CINCH investigators. Cooling in intracerebral hemorrhage (CINCH) trial: protocol of a randomized German-Austrian clinical trial. Int J Stroke. 2012;7(2):168–72.PubMedCrossRef

34.

Bladin CF, Alexandrov AV, Bellavance A, Bornstein N, Chambers B, Coté R, Lebrun L, Pirisi A, Norris JW. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000;57(11):1617–22.PubMedCrossRef

35.

Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65(4):476–83.PubMedCrossRef

36.

Kuhmonen J, Piippo A, Väärt K, Karatas A, Ishii K, Winkler P, Niemelä M, Porras M, Hernesniemi J. Early surgery for ruptured cerebral arteriovenous malformations. Acta Neurochir Suppl. 2005;94:111–4.PubMedCrossRef

37.

Brown RD. Simple risk predictions for arteriovenous malformation hemorrhage. Neurosurgery. 2000;46(4):1024.PubMed

38.

Mohr JP, Moskowitz AJ, Stapf C, et al. The ARUBA trial: current status, future hopes. Stroke. 2010;41(8):e537–40.PubMedCrossRef

39.

Brown RD, Flemming KD, Meyer FB, Cloft HJ, Pollock BE, Link ML. Natural history, evaluation, and management of intracranial vascular malformations. Mayo Clin Proc. 2005;80(2):269–81.PubMedCrossRef

40.

Hartmann A, Pile-Spellman J, Stapf C, Sciacca RR, Faulstich A, Mohr JP, Schumacher HC, Mast H. Risk of endovascular treatment of brain arteriovenous malformations. Stroke. 2002;33(7):1816–20.PubMedCrossRef

41.

Pikus HJ, Beach ML, Harbaugh RE. Microsurgical treatment of arteriovenous malformations: analysis and comparison with stereotactic radiosurgery. J Neurosurg. 1998;88(4):641–6.PubMedCrossRef

42.

Maruyama K, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD. Stereotactic radiosurgery for brainstem arteriovenous malformations: factors affecting outcome. J Neurosurg. 2004;100(3):407–13.PubMedCrossRef

43.

Maruyama K, Koga T, Shin M, Igaki H, Tago M, Saito N. Optimal timing for Gamma Knife surgery after hemorrhage from brain arteriovenous malformations. J Neurosurg. 2008;109(Suppl):73–6.PubMed

44.

Maruyama K, Kawahara N, Shin M, Tago M, Kishimoto J, Kurita H, Kawamoto S, Morita A, Kirino T. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med. 2005;352(2):146–53.PubMedCrossRef

Titel: Management of Ruptured Brain Arteriovenous Malformations
verfasst von: Brad E. Zacharia
Kerry A. Vaughan
Adam Jacoby
Zachary L. Hickman
Daniel Bodmer
E. Sander Connolly Jr.
Publikationsdatum: 01.08.2012
Verlag: Current Science Inc.
Erschienen in: Current Atherosclerosis Reports / Ausgabe 4/2012
Print ISSN: 1523-3804
Elektronische ISSN: 1534-6242
DOI: https://doi.org/10.1007/s11883-012-0257-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2012

Nonaneurysmal Subarachnoid Hemorrhage: An Update

Management of Hemorrhage from Cavernous Malformations

Medical Versus Surgical Management of Intracerebral Hematomas

Etiologies of Intracerebral Hematomas

Anticoagulation-Related Intracranial Hemorrhages